Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237935 · ClinicalTrials.gov registry record
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
A clinical trial of Antiplatelet, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 27,960
- Enrollment target
- 1
- Study location
NCT04237935 is a study of Antiplatelet that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 27,960 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04237935, a study of Antiplatelet, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 27,960 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG Ticagrelor 90mg
- DRUG Clopidogrel 75mg
Study Locations (1)
Massachusetts
- Brigham And Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,960 participants |
| Start Date | 2019-09-22 |
| Est. Completion | 2021-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04237935
The ClinicalTrials.gov registry entry for NCT04237935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27,960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Antiplatelet appearing as the primary indexed condition, and to 2 interventions - of which Ticagrelor 90mg is the first listed.
NCT04237935 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04237935 about?
NCT04237935 is a clinical study titled "Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04237935?
This trial is currently completed. The enrollment target is 27,960 participants. The study started on 2019-09-22. Estimated completion is 2021-02-18.
What conditions does trial NCT04237935 study?
This clinical trial studies the following conditions: Antiplatelet.
What interventions are being tested in trial NCT04237935?
The interventions under investigation include: Ticagrelor 90mg (DRUG), Clopidogrel 75mg (DRUG).
Who is sponsoring clinical trial NCT04237935?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237935 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.